Stay updated on Novel Therapeutics for High-Risk AML Clinical Trial
Sign up to get notified when there's something new on the Novel Therapeutics for High-Risk AML Clinical Trial page.

Latest updates to the Novel Therapeutics for High-Risk AML Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA new version 262 dated 2026-09-22 adds the Contacts/Locations and Study Status sections to the study record history; the version dated 2026-09-18 was removed.SummaryDifference0.1%

- Check16 days agoChange DetectedA new revision (v3.7.0) is added to the record history, introducing entries for Find contact information, Contacts/Locations, and Study Status, dated 2026-09-15 to 2026-09-18, while an older revision (v3.6.6) is removed.SummaryDifference0.2%

- Check38 days agoChange DetectedThe page history shows a new revision entry (v3.6.6) with added sections for Contacts/Locations and Study Status, and the preceding revision (v3.6.5) was removed. This reflects an update to the history-tracking UI and versioning metadata rather than substantive study data changes.SummaryDifference0.1%

- Check45 days agoChange DetectedRecent history entries document updated Study Status and Contacts/Locations for August 2026 (versions 256–258), with an older August 13 entry removed.SummaryDifference0.2%

- Check52 days agoChange DetectedNew history entries were added for versions 254 (2026-08-07) and 255 (2026-08-12), and the 2026-08-13 update adds the Study Status and Contacts/Locations sections to the record history; an earlier entry from 2026-08-05 was removed.SummaryDifference0.1%

- Check59 days agoChange DetectedVersion 3.6.5 was added on 2026-08-05, introducing updates to the Study Status and Contacts/Locations sections. The history also records **Revision: v3.6.5** and removes the prior **Revision: v3.6.4** entry.SummaryDifference0.2%

Stay in the know with updates to Novel Therapeutics for High-Risk AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Novel Therapeutics for High-Risk AML Clinical Trial page.